1.
Outcome of Solifenacin Monotherapy and Combined Solifenacin and Mirabegron Therapy in Patient with Overactive Bladder. J. Com. Med. Col. Teachers Asso. 2024;28(2):75-81. doi:10.3329/jcomcta.v28i2.78017